Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis B

Introduction: Although pegylated interferons (pegIFNs) alpha-2a and alpha-2b have been used in chronic hepatitis B (CHB) treatment for many years, there are few studies concerning predictors of sustained virologic response (SVR) to pegIFN therapy. In this study, we aimed to investigate the predictor...

Full description

Bibliographic Details
Published in:Journal of Infection in Developing Countries
Main Authors: Ertugrul Guclu, Nazan Tuna, Oguz Karabay, Sıla Akhan, Hurrem Bodur, Bahadır Ceylan, Tuna Demirdal, Kutbettin Demirdag, Nese Demirturk, Hasan Ekerbicer, Serpil Erol, Saban Esen, Omer Evirgen, Mehmet Faruk Geyik, Alper Gunduz, Mustafa Kasım Karahocagil, Omer Faruk Kokoglu, Davut Ozdemir, Nail Ozgunes, Fatma Sargın, Selma Tosun, Ediz Tutuncu
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2014-12-01
Subjects:
Online Access:https://jidc.org/index.php/journal/article/view/4953